Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: oxybutynin chloride

« Back to Dashboard

Summary for Generic Name: oxybutynin chloride

Drug Master File Entries: see list16
Suppliers: see list5
Therapeutic Class:Genitourinary Agents

Pharmacology for Ingredient: oxybutynin chloride

Clinical Trials for: oxybutynin chloride

OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER in Spinal Cord Injured Veterans With Neurogenic Detrusor Overactivity
Status: Recruiting Condition: Neurogenic Detrusor Overactivity

Use of Oxybutynin for Treating Hyperhidrosis: A Placebo-control Study
Status: Completed Condition: Hyperhidrosis

Treatment of Hyperhidrosis With Oxybutynin
Status: Completed Condition: Hyperhidrosis

Evaluate the Efficacy of Oxybutynin Chloride in Patients With Primary Hyperhidrosis
Status: Not yet recruiting Condition: Primary Hyperidrosis

A Study to Compare Oxybutynin to a Placebo in Women and the Effect on Plantar Hyperhidrosis
Status: Completed Condition: Hyperhidrosis

An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder Participants
Status: Completed Condition: Urinary Bladder, Overactive

Desloratadine With Oxybutynin for the Treatment of Seasonal Allergic Rhinitis and Post-Nasal Drip (Study P04258)(COMPLETED)
Status: Completed Condition: Post-Nasal Drip; Seasonal Allergic Rhinitis; Rhinorrhea

Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence
Status: Completed Condition: Urge Urinary Incontinence; Urinary Frequency

Use of Oxybutynin to Treat Axillary Hyperhidrosis
Status: Completed Condition: Axillary Hyperhidrosis; Osmidrosis

A Study of Fesoterodine and Oxybutynin on Cognitive Function in Mild Cognitive Impairment
Status: Not yet recruiting Condition: Overactive Bladder; Mild Cognitive Impairment

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
oxybutynin chloride
SYRUP;ORAL074997Oct 15, 1997DISCNNo<disabled><disabled>
Usl Pharma
oxybutynin chloride
TABLET;ORAL070746Mar 10, 1988DISCNNo<disabled><disabled>
Impax Pharms
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL076745May 9, 2007RXNo<disabled><disabled>
oxybutynin chloride
SYRUP;ORAL074868Feb 12, 1997RXYes<disabled><disabled>
Janssen Pharms
oxybutynin chloride
TABLET;ORAL017577Approved Prior to Jan 1, 1982DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology